DIA
SGMO

Denver Investment Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Denver Investment Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-14,314
Closed -$81K – 528
2015
Q3 		$81K Sell
14,314
-493
-3% -$4.07K ﹤0.01% 513
2015
Q2 		$164K Buy
+14,807
New +$191K 0.01% 517

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Denver Investment Advisors's SGMO Position: Q4 2015 in Review

Denver Investment Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2015, closing a stake of 14,314 shares — an estimated $81K sold.

Denver Investment Advisors first reported a position in SGMO in Q2 2015 and held it in 2 quarters. The position peaked at $164K in Q2 2015. 141 funds tracked by Wall St. Rank hold SGMO as of Q4 2015.

  • Denver Investment Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2015 after selling out during the quarter.
  • Denver Investment Advisors sold 14,314 SANGAMO THERAPEUTICS INC shares in Q4 2015, an estimated $81K.
  • Denver Investment Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q2 2015 and held it in 2 quarters.
  • Denver Investment Advisors's SANGAMO THERAPEUTICS INC position peaked at $164K in Q2 2015.
  • 141 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2015.

Based on Denver Investment Advisors's 13F filing for Q4 2015, filed 3 Feb 2016.